CoChat

Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis

Open access
Campa, Carlo C., Silva, Rangel L., Margaria, Jean P., Pirali, Tracey, Mattos, Matheus S., Kraemer, Lucas R., Reis, Diego C., Grosa, Giorgio, Copperi, Francesca, Dalmarco, Eduardo M., Lima-Júnior, Roberto C. P., Aprile, Silvio, Sala, Valentina, Dal Bello, Federica, Prado, Douglas Silva, Alves-Filho, Jose Carlos, Medana, Claudio, Cassali, Geovanni D., Tron, Gian Cesare, Teixeira, Mauro M., Ciraolo, Elisa, Russo, Remo C., Hirsch, Emilio · 2018 · Nature Communications
Cited by 113

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

PI3K activation plays a central role in the development of pulmonary inflammation and tissue remodeling. PI3K inhibitors may thus offer an improved therapeutic opportunity to treat non-resolving lung inflammation but their action is limited by unwanted on-target systemic toxicity. Here we present CL27c, a prodrug pan-PI3K inhibitor designed for local therapy, and investigate whether inhaled CL27c is effective in asthma and pulmonary fibrosis. Mice inhaling CL27c show reduced insulin-evoked Akt phosphorylation in lungs, but no change in other tissues and no increase in blood glycaemia, in line with a local action. In murine models of acute or glucocorticoid-resistant neutrophilic asthma, inhaled CL27c reduces inflammation and improves lung function. Finally, inhaled CL27c administered in a therapeutic setting protects from bleomycin-induced lung fibrosis, ultimately leading to significantly improved survival. Therefore, local delivery of a pan-PI3K inhibitor prodrug reduces systemic on-target side effects but effectively treats asthma and irreversible pulmonary fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-07698-6

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 113

Metadata

Authors
Campa, C. C., Silva, R. L., Margaria, J. P., Pirali, T., Mattos, M. S., Kraemer, L. R., Reis, D. C., Grosa, G., Copperi, F., Dalmarco, E. M., Lima-Júnior, R. C. P., Aprile, S., Sala, V., Dal Bello, F., Prado, D. S., Alves-Filho, J. C., Medana, C., Cassali, G. D., Tron, G. C., Teixeira, M. M., Ciraolo, E., Russo, R. C., & Hirsch, E.
Venue
Nature Communications
Published
2018-12-12
Volume
9
Issue
1
Pages
5232-5232
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2902094068
Cited by
113
References
5
FWCI
6.59
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis. https://app.cochat.ai/papers/10.1038/s41467-018-07698-6
The paper
Campa, C. C., Silva, R. L., Margaria, J. P., Pirali, T., Mattos, M. S., Kraemer, L. R., Reis, D. C., Grosa, G., Copperi, F., Dalmarco, E. M., Lima-Júnior, R. C. P., Aprile, S., Sala, V., Dal Bello, F., Prado, D. S., Alves-Filho, J. C., Medana, C., Cassali, G. D., Tron, G. C., . . . Hirsch, E. (2018). Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis. Nature Communications. https://doi.org/10.1038/s41467-018-07698-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.